SynthesisCannabis and cannabinoid research2024
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions.
Open access · hybridAbstract readSystematic Review
In one paragraph
Synthesis in Cannabis and cannabinoid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 62 citations in OpenAlex.
- Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Trial
- Therapeutic Potential of Cannabidiol in Dysbiosis-Related Oral Biofilm Diseases: Antibiofilm, Antivirulence and Host Response Evidence.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Impact of Sleep Disturbances Treatment in Patients With Fibromyalgia: A Scoping Review.Journal of sleep research · 2026Article
- Article
- Knowledge, Attitudes, and Clinical Experience with Cannabinoid Therapies: A Cross-Sectional Survey of Rheumatologists.Mediterranean journal of rheumatology · 2026Article
- The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.Clinical rheumatology · 2026Article
- Mapping the research landscape of minor cannabinoids: a bibliometric analysis of research trends and hotspots.Journal of cannabis research · 2026Article
- CARE - A Retrospective, Dual-Cohort, 24-Week Real-World Study from the German Pain e-Registry on the Effectiveness and Safety of CBD-Dominant Oral Cannabis Extracts versus THC/Dronabinol in Older Patients with Chronic Pain.Journal of pain research · 2026Article
- Correlates of Recreational and Medicinal Cannabis Use Among Non-Hispanic Black and Hispanic Men with Chronic Conditions.Journal of community health · 2025Article
- The Present and Future of Pain Management in Patients With Chronic Kidney Disease: A Narrative Review.Cureus · 2025Review
- Cannabinoids in Chronic Pain: Clinical Outcomes, Adverse Effects and Legal Challenges.Neurology international · 2025Review
- Review
- A Review on the Management of Symptoms in Patients with Incurable Cancer.Current oncology (Toronto, Ont.) · 2025Review
- Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence Treatment.Drug and alcohol review · 2025Article
- Efficacy of Cannabis Oil in Improving Subjective Sleep Quality in Systemic Sclerosis: A Prospective Placebo-Controlled Study.Life (Basel, Switzerland) · 2025Article
- The Complex Interplay of Prescription Drug Monitoring Programs, Regulated Medical Cannabis, and Chronic Pain Healthcare Visits.Journal of general internal medicine · 2025Article
- Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain.Drug and alcohol review · 2025Article
- Feasibility pilot of a novel coaching intervention to optimize cannabis use for chronic pain management among Veterans.Journal of cannabis research · 2025Article
- Reducing medical cannabis use risk among Veterans: A descriptive study.Harm reduction journal · 2025Article
- Chronic Pain and Comorbid Emotional Disorders: Neural Circuitry and Neuroimmunity Pathways.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 12 institutions in 1 country.
Alan D BellDepartment of Family and Community Medicine, University of Toronto, Toronto, Canada.
Caroline MacCallumFaculty of Medicine, Department of Internal Medicine, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-7889-3959
Shari MargoleseCanadian HIV Trials Network, University of British Columbia, Vancouver, Canada.
Zach WalshDepartment of Psychology, University of British Columbia, Kelowna, Canada.
Patrick WrightCanadian AIDS Society, Ottawa, Canada.
Paul J DaeninckDepartment of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
Enrico MandarinoCanadian HIV Trials Network, University of British Columbia, Vancouver, Canada.
Gary LacasseCanadian AIDS Society, Ottawa, Canada.ORCID 0000-0001-5323-0828
Jagpaul Kaur DeolFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Lauren de FreitasCentre for Addiction and Mental Health, Institute for Mental Health Policy Research, Toronto, Canada.
Michelle St PierreDepartment of Psychology, University of British Columbia, Kelowna, Canada.ORCID 0000-0002-4522-3166
Lynne Belle-IsleCanadian AIDS Society, Ottawa, Canada.
Marilou GagnonCanadian Institute for Substance Use Research, University of Victoria, Victoria, Canada.
Sian BevanArthritis Society, Toronto, Canada.
Tatiana SanchezDepartment of Psychology, University of British Columbia, Kelowna, Canada.
Stephanie ArltCentre for Addiction and Mental Health, Institute for Mental Health Policy Research, Toronto, Canada.
Max Monahan-EllisonMedical Cannabis Canada, Toronto, Canada.
James O'HaraIndependent Consultant, Toronto, Canada.
Michael BoivinCommParm Consulting, Inc., Barrie, Ontario, Canada.
Cecilia CostiniukChronic Viral Illness Service/Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Canada.ORCID 0000-0002-4547-714X
University of British Columbia · CACanadian AIDS Society · CACentre for Addiction and Mental Health · CAArthritis Society · CABarrie Urology Group · CACanBiocin (Canada) · CACancerCare Manitoba · CAHIV Legal Network · CAMcGill University Health Centre · CATD Bank Group · CAUniversity of Toronto · CAUniversity of Victoria · CA
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
CannabinoidsChronic PainMedical MarijuanaAnxietyCannabisHumansPain ManagementPractice Guidelines as TopicSleep Wake DisordersSubstance-Related DisordersCannabinoidsMedical Marijuanacannabinoid-based medicinescannabinoidscannabischronic painmarijuanasleep disorders
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.